Our data suggest that by inhibiting miR-570-3p in COPD SAECs, we can reduce expression of MMP-2/9, IL-1β, IL-6, and CXCL8 (44, 46, 47). Here, MMP2 is linked to chronic obstructive pulmonary disease.